Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Half Yearly Results - GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 14, 16:00
1601.25
-3.35 (-0.21%)
VOLUME 3,568
LIVE
NSE
Nov 14, 15:55
1601.25
-3.55 (-0.22%)
VOLUME 39,755

Half Yearly Results of GlaxoSmithKline Pharmaceuticals

------------------- in Rs. Cr. -------------------
Sep '19 Mar '19 Mar '18 Sep '17 Mar '17
Net Sales/Income from operations 1,670.12 1,576.57 1,452.53 1,443.35 1,452.72
Other Operating Income -- -- -- -- 37.34
Total Income From Operations 1,670.12 1,576.57 1,452.53 1,443.35 1,490.06
EXPENDITURE
Consumption of Raw Materials 263.60 353.16 233.50 276.77 220.37
Purchase of Traded Goods 429.00 326.95 383.13 405.29 406.65
Increase/Decrease in Stocks 8.06 7.56 -23.36 -34.58 90.97
Power & Fuel -- -- -- -- --
Employees Cost 290.28 271.69 255.61 267.79 237.98
Depreciation 41.76 25.72 22.74 15.25 14.40
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 319.46 316.26 306.98 316.31 345.24
P/L Before Other Inc. , Int., Excpt. Items & Tax 317.96 275.23 273.93 196.52 174.45
Other Income 46.15 68.88 30.25 23.27 29.66
P/L Before Int., Excpt. Items & Tax 364.11 344.11 304.18 219.79 204.11
Interest 1.85 0.13 0.19 -- --
P/L Before Exceptional Items & Tax 362.26 343.98 303.99 219.79 204.11
Exceptional Items 401.14 24.96 -- 17.80 43.75
P/L Before Tax 763.40 368.94 303.99 237.59 247.86
Tax 147.15 132.94 108.75 80.85 82.20
P/L After Tax from Ordinary Activities 616.25 236.00 195.24 156.74 165.66
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 616.25 236.00 195.24 156.74 165.66
Equity Share Capital 169.41 169.41 84.70 84.70 84.70
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 36.38 -- -- 18.50 --
Diluted EPS 36.38 -- -- 18.50 --
EPS After Extra Ordinary
Basic EPS 36.38 -- -- 18.50 --
Diluted EPS 36.38 -- -- 18.50 --
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of GlaxoSmithKline

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for glaxosmithklinepharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.